Phio Pharmaceuticals Corp.

PHIO | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.01

-$0.02 (-1.94%)

At close: Sep 21, 2026, 4:00 PM ET

$1.02

+$0.01 (+0.99%)

Pre-market: Sep 22, 2026, 4:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $11.97M

Enterprise Value $-1.26M

Beta 0.80

Average Volume 477.21K

Shares Outstanding (Diluted) 11.62M

Shares Change YoY 142.29%

Institutional Ownership 5.75%

Exchange NASDAQ

ISIN US71880W5013

Price Performance

Price Change 1M -14.4%

Price Change 3M -2.9%

Price Change 6M -19.8%

Price Change YTD -7.3%

Price Change 1Y -54.9%

Price Change 3Y -91.9%

Price Change 5Y -99.6%

1M CAGR (ann.) -2.8%

1Y CAGR (ann.) -51.2%

5Y CAGR (ann.) -65.8%

All-Time CAGR -26.6%

Valuation

PE Ratio -0.75

Forward PE N/A

PEG Ratio -0.01

Forward PEG 0.01

PS Ratio N/A

Forward PS N/A

PB Ratio 0.93

P/FCF Ratio -0.72

P/Adj. FCF Ratio -0.68

P/OCF Ratio -0.96

EV/Sales N/A

EV/EBIT 0.14

EV/EBITDA 0.14

EV/FCF 0.08

Earnings Yield -132.7%

FCF Yield -138.2%

Adj. FCF Yield -146.9%

Financial Health

Net Cash $13M

Total Debt $0

Cash & Short-Term Investments $13M

Total Assets $14.31M

Current Ratio 15.87

Quick Ratio 15.87

Debt / Equity Ratio 0.00

Debt / EBITDA -0.00

Debt / FCF -0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score -12.66

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -6.3%

Returns

Return on Assets -90.2%

Return on Equity -87.4%

Return on Invested Capital -100.5%

Return on Capital Employed -100.5%

Return on Tangible Assets -90.2%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y -37.0%

EPS CAGR 3Y 0.1%

EPS CAGR 5Y -49.4%

EPS CAGR 10Y 20.1%

FCF CAGR 3Y -33.1%

FCF CAGR 5Y -4.6%

FCF CAGR 10Y -4.8%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 1

EPS Growth Next 3Y N/A

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.36

EPS Growth Est (next Q) -18.2%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $14

Price Target Upside 1286.1%

Cash Flow

Operating Cash Flow $-16.21M

Free Cash Flow $-16.21M

Adj. Free Cash Flow $-17.24M

FCF Per Share -$1.05

OCF Per Share -$1.05

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-2.66M

Operating Income $-9.21M

EBITDA $-8.76M

Net Income $-12.9M

EPS (Diluted) -$1.34

Revenue / Employee N/A

Profit / Employee $-2.15M

Employees 6